AU2003269620A1 - Use of a combination of a taxane with dppe for the treatment of cancer - Google Patents

Use of a combination of a taxane with dppe for the treatment of cancer

Info

Publication number
AU2003269620A1
AU2003269620A1 AU2003269620A AU2003269620A AU2003269620A1 AU 2003269620 A1 AU2003269620 A1 AU 2003269620A1 AU 2003269620 A AU2003269620 A AU 2003269620A AU 2003269620 A AU2003269620 A AU 2003269620A AU 2003269620 A1 AU2003269620 A1 AU 2003269620A1
Authority
AU
Australia
Prior art keywords
dppe
taxane
cancer
treatment
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003269620A
Inventor
Lorne J. Brandes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manitoba
Original Assignee
University of Manitoba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manitoba filed Critical University of Manitoba
Publication of AU2003269620A1 publication Critical patent/AU2003269620A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003269620A 2002-09-03 2003-09-02 Use of a combination of a taxane with dppe for the treatment of cancer Abandoned AU2003269620A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40724302P 2002-09-03 2002-09-03
US60/407,243 2002-09-03
PCT/CA2003/001334 WO2004022044A1 (en) 2002-09-03 2003-09-02 Use of a combination of a taxane with dppe for the treatment of cancer

Publications (1)

Publication Number Publication Date
AU2003269620A1 true AU2003269620A1 (en) 2004-03-29

Family

ID=31978444

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003269620A Abandoned AU2003269620A1 (en) 2002-09-03 2003-09-02 Use of a combination of a taxane with dppe for the treatment of cancer

Country Status (2)

Country Link
AU (1) AU2003269620A1 (en)
WO (1) WO2004022044A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL369792A1 (en) * 2001-11-01 2005-05-02 Ym Biosciences, Inc. Use of n,n-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (dppe) in cancer therapy

Also Published As

Publication number Publication date
WO2004022044A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
AUPS054702A0 (en) Cancer therapy
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
AU2003296475A1 (en) Phototherapy bandage
HK1072443A1 (en) Immunoconjugates for the treatment of tumours
AU2003212634A1 (en) Compounds useful in the treatment of cancer
GB0218526D0 (en) Combination therapy
AU2003247005A1 (en) Therapy combination
AU2003251904A1 (en) Combinations of drugs for the treatment of neoplasms
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003251875A1 (en) Combination therapy for the treatment of neoplasms
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003222449A1 (en) Medicine for treating cancer
AU2003215150A1 (en) Therapeutic compounds
AUPR320701A0 (en) The new cancer therapeutic agent with a thiopeptides
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2003255727A1 (en) Syringes
AU2003231803A1 (en) Treatment of cancer with mefloquire
AU2003283339A1 (en) Cancer therapy determination
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
AU2003269620A1 (en) Use of a combination of a taxane with dppe for the treatment of cancer
AU2003266049A1 (en) Use of a combination of dppe with other chemotherapeutic agents for the treatment of breast cancer
AU2003299399A1 (en) Use of a specific inhibitor of the 5ht2b receptor for the treatment of cancer
GB2383538B (en) Cancer treatment
AU2003239442A1 (en) Agents which interact with a serotonin transporter for the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase